1. Home
  2. SLN vs MPX Comparison

SLN vs MPX Comparison

Compare SLN & MPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • MPX
  • Stock Information
  • Founded
  • SLN 1994
  • MPX 1965
  • Country
  • SLN United Kingdom
  • MPX United States
  • Employees
  • SLN N/A
  • MPX N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • MPX Marine Transportation
  • Sector
  • SLN Health Care
  • MPX Industrials
  • Exchange
  • SLN Nasdaq
  • MPX Nasdaq
  • Market Cap
  • SLN 223.4M
  • MPX 326.0M
  • IPO Year
  • SLN N/A
  • MPX N/A
  • Fundamental
  • Price
  • SLN $4.23
  • MPX $8.51
  • Analyst Decision
  • SLN Buy
  • MPX Hold
  • Analyst Count
  • SLN 5
  • MPX 1
  • Target Price
  • SLN $40.80
  • MPX $8.00
  • AVG Volume (30 Days)
  • SLN 282.3K
  • MPX 28.4K
  • Earning Date
  • SLN 02-27-2025
  • MPX 04-24-2025
  • Dividend Yield
  • SLN N/A
  • MPX 6.58%
  • EPS Growth
  • SLN N/A
  • MPX N/A
  • EPS
  • SLN N/A
  • MPX 0.50
  • Revenue
  • SLN $43,258,000.00
  • MPX $236,555,000.00
  • Revenue This Year
  • SLN N/A
  • MPX $3.97
  • Revenue Next Year
  • SLN N/A
  • MPX $13.02
  • P/E Ratio
  • SLN N/A
  • MPX $16.90
  • Revenue Growth
  • SLN 36.71
  • MPX N/A
  • 52 Week Low
  • SLN $4.06
  • MPX $8.22
  • 52 Week High
  • SLN $27.72
  • MPX $12.47
  • Technical
  • Relative Strength Index (RSI)
  • SLN 41.17
  • MPX 43.63
  • Support Level
  • SLN $4.10
  • MPX $8.22
  • Resistance Level
  • SLN $5.23
  • MPX $8.93
  • Average True Range (ATR)
  • SLN 0.40
  • MPX 0.25
  • MACD
  • SLN 0.06
  • MPX 0.01
  • Stochastic Oscillator
  • SLN 33.90
  • MPX 40.14

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About MPX Marine Products Corporation

Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.

Share on Social Networks: